• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

8
8
6
5
4

COUNTRY

3
2
2
1
1

PRICE

5
26
26
33

PUBLISHED

0
11
11
33

PRODUCT TYPE

30
3

Analgesics

(33 Products)

Which will be the fastest growing segment within the analgesics market this year? Which company accounted for the largest share of the UK analgesics market last year? What are the key distribution channels in the United States? Which is the leading country for analgesics in emerging economies?

The answers to these – and many more – market questions can be found in the reports, books, and subscriptions listed under Research and Markets’ Analgesics category. Our publications provide expert analysis of every aspect of the painkiller industry; for instance market trends, growth sectors, leading brands (e.g. paracetamol, ibuprofen and aspirin), and forecasts.

Key players featured include GlaxoSmithKline, United Laboratories, Bayer AG, Johnson & Johnson, and more.

For publications about vitamins, minerals and supplements please visit the Vitamins category. Show Less
Read more

Analgesics in the United Arab Emirates

Analgesics saw 7% current value growth in 2014, which was similar to the current value CAGR of 6% recorded over the review period. Analgesics is an OTC consumer health category which is entering maturity,...

June 2015
FROM

Analgesics in Indonesia

The leading companies in analgesics are trying to increase brand awareness through Corporate Social Responsibility (CSR) programmes. Leading companies, such as Tempo Scan Pacific and Sterling Products,...

June 2015
FROM

Analgesics in Belgium

From the end of 2013, sales of analgesics were strongly under pressure. Firstly, sales continued to rely on the number and intensity of viruses, and thus often on climatic conditions. In contrast with...

June 2015
FROM

Analgesics in France

Most players were rather disappointed by the performance of analgesics in 2014. First, by contrast with the cold winter and the rainy spring in 2013, the weather was very mild in the winter, spring...

June 2015
FROM

Analgesics in the Philippines

In order to stimulate growth in analgesics, players committed financial resources to promotional campaigns and other marketing efforts in 2014. Television advertisements which featured key celebrities...

June 2015
FROM

Analgesics in Thailand

Analgesics recorded similar current value growth in 2014 to 2013, due to consumers’ hectic lifestyles. The latter saw consumers seeking quick pain relief so they could carry on with their daily schedules,...

June 2015
FROM

Analgesics in Algeria

Prior to the review period, the Algerian government imposed strict controls on pharmaceutical imports. However, there was insufficient domestic production capacity to meet growing demand for analgesics...

June 2015
FROM

Analgesics in Malaysia

Consumers in Malaysia use analgesics products such as adult acetaminophen and paediatric acetaminophen as the most common type of self-cure treatments. Due to the low dosage contained in analgesics...

May 2015
FROM

Analgesics in Peru

In Peru, analgesics sales lead OTC. Since a notable amount of the population cannot afford healthcare, it is common for customers to purchase this medication for minor aches or physical discomfort....

May 2015
FROM

Analgesics in Uruguay

Analgesics was one of the most dynamic OTC consumer health categories in Uruguay in 2014, with growth slightly behind digestive remedies and dermatologicals, the latter of which was the most dynamic...

May 2015
FROM

Analgesics in South Africa

With economic and socioeconomic constraints continuing to face the country, rising utility and inflationary pressures continued to leave mass South Africans under strained household financial circumstances....

May 2015
FROM

Apparel in Australia

Despite the nation’s relatively sound economic position, pessimism pervaded consumer sentiment in Australia over the review period, leading to some of the highest household savings rates seen in the...

June 2013
FROM

Analgesics in Kazakhstan

Towards the end of review period, analgesics was driven by the stressful and hectic lifestyle of many Kazakh consumers, particularly urban citizens, which supported the increasing demand for analgesics....

April 2013
FROM

06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012. All companies include technology, market(s), key executive,...

June 2012
FROM

01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 47 emerging medical technology companies that have been identified by LSI's in-house research team in January 2012. All companies include technology, market(s), key...

January 2012
FROM

U.S. Long-Term Acute Care Markets

Faced with escalating costs, acute hospitals require alternative care locations to accommodate the needs of extended-stay patients, who account for a substantial proportion of healthcare expenditures...

January 2012
FROM

Analgesics - Hong Kong, China

Analgesics continued to see steady growth in value sales in 2010, of 4%, which was in line with the review period average. Growth was driven by a strong performance by topical analgesics. The Analgesics...

March 2011
FROM

Analgesics - Singapore

Topical analgesics brands were aggressively marketed in 2010, which contributed to their better performance compared to systemic analgesics. Salonpas, which is marketed by Hisamitsu Pharmaceutical Co...

March 2011
FROM

Analgesics - Canada

Sales of analgesics continued to show strong growth of 4% in 2010, reaching C$766 million in current value terms. Growth was largely driven by Canada’s rapidly ageing population as seniors increasingly...

March 2011
FROM

Analgesics - China

In line with the stable performance of China’s OTC market, analgesics also demonstrated stable growth during 2010, with current value growth of just over 9% and total sales of RMB5.1 billion by the...

February 2011
FROM
Loading Indicator

Our Clients

Baxter International Inc. Endo International Plc. Medtronic, Inc. Johnson & Johnson Services, Inc. Procter & Gamble Co. Purdue Pharma L.P.